GLPGF
Price:
$28.08
Market Cap:
$1.61B
Galapagos N.V. is a fully-integrated biopharmaceutical firm dedicated to discovering, developing, and bringing to market innovative therapies for conditions where patient needs are largely unaddressed. The company boasts a robust pipeline of investigational drugs, prominently featuring: Filgotinib: A potent JAK1 inhibitor, currently undergoing multiple phases of clinical evaluation for a broad spectrum of inflammatory and autoimmune disorders, such as rheumatoid arthritis, Crohn's disease (including small bowel and fistulizing forms), ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. GLPG1972: This key candidate has successfully completed its Phase 2b trial target...[Read more]
Industry
Biotechnology
IPO Date
2009-08-03
Stock Exchange
OTC
Ticker
GLPGF
According to Galapagos N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -3.50. This represents a change of -157.67% compared to the average of 6.07 of the last 4 quarters.
The mean historical PE Ratio of Galapagos N.V. over the last ten years is -6.79. The current -3.50 PE Ratio has changed 5.06% with respect to the historical average. Over the past ten years (40 quarters), GLPGF's PE Ratio was at its highest in in the June 2023 quarter at 120.70. The PE Ratio was at its lowest in in the June 2016 quarter at -153.78.
Average
-6.79
Median
-3.35
Minimum
-143.86
Maximum
71.73
Discovering the peaks and valleys of Galapagos N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 332.24%
Maximum Annual PE Ratio = 71.73
Minimum Annual Increase = -397.15%
Minimum Annual PE Ratio = -143.86
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 5.75 | -75.72% |
| 2024 | 23.68 | 105.48% |
| 2023 | 11.52 | -192.52% |
| 2022 | -12.45 | -51.67% |
| 2021 | -25.77 | 53.06% |
| 2020 | -16.84 | -123.47% |
| 2019 | 71.73 | -149.86% |
| 2018 | -143.86 | 332.24% |
| 2017 | -33.28 | -164.45% |
| 2016 | 51.64 | -397.15% |
The current PE Ratio of Galapagos N.V. (GLPGF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
13.65
5-year avg
0.55
10-year avg
-6.79
Galapagos N.V.’s PE Ratio is less than Bavarian Nordic A/S (12.02), greater than Ryman Healthcare Limited (-13.80), less than Bavarian Nordic A/S (12.02), greater than Telix Pharmaceuticals Limited (-451.71), less than Gedeon Richter PLC (9.34), less than Shandong Weigao Group Medical Polymer Company Limited (8.02), less than MediPal Holdings Corporation (12.54), less than Shandong Weigao Group Medical Polymer Company Limited (8.02), less than Ansell Limited (21.92), greater than Oxford Nanopore Technologies plc (-7.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| 12.02 | $2.14B | |
| -13.80 | $1.43B | |
| 12.02 | $2.12B | |
| -451.71 | $3.40B | |
| 9.34 | $7.01B | |
| 8.02 | $1.91B | |
| 12.54 | $3.22B | |
| 8.02 | $1.91B | |
| 21.92 | $2.97B | |
| -7.90 | $1.53B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galapagos N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galapagos N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Galapagos N.V.'s PE Ratio?
How is the PE Ratio calculated for Galapagos N.V. (GLPGF)?
What is the highest PE Ratio for Galapagos N.V. (GLPGF)?
What is the 3-year average PE Ratio for Galapagos N.V. (GLPGF)?
What is the 5-year average PE Ratio for Galapagos N.V. (GLPGF)?
How does the current PE Ratio for Galapagos N.V. (GLPGF) compare to its historical average?